INTRODUCTION {#sec1-1}
============

Cerebral shunts are indicated for Hydrocephalus to drain the CSF into a cavity to prevent the increase in intracranial pressure.\[[@ref1]\] Hydrocephalus could be congenital or due to a tumor, aqueductal stenosis, craniosynostosis, Dandy-Walker syndrome or Idiopathic Intracranial Hypertension. A commonly used route for the shunt is the ventriculoperitoneal (VP) shunt, which drains CSF into the peritoneal cavity. The other routes that are used are ventriculo-atrial, ventriculo-pleural, and lumbar-peritoneal. The complications that can occur with a shunt are infection, blockage, and overdrainage.

There are various shunts, all of which have a unidirectional valve system in place to prevent the retrograde infection or increase in pressure.

Advances in surgeries of cerebral shunts and the increased life span associated with them, has made the incidence of patients with VP shunts presenting with an indication for laparoscopy higher.

A few questions that arise:

Whether the pneumoperitoneum created during a laparoscopy procedure will cause retrograde diffusion of gases into the ventricles causing increased intracranial pressure and associated complications?Whether the shunt can get infected and cause meningitis?The effect of CO~2~ on the brain as the shunt connects two cavities?What pre-operative counseling is required for such patients?

CASE REPORT {#sec1-2}
===========

A 32-year lady came with complaints of bleeding P.V. following 1½ months of amenorrhea and pain in the left lower abdomen since 2 days and her UPT was weakly positive. An ultrasound examination revealed a 4.5 cm left ectopic tubal pregnancy with no intrauterine gestation and with free fluid in the POD. She was operated 10 years back for a VP shunt in view of a normal pressure hydrocephalus. She has 3 children, first two delivered vaginally and her last child birth was by cesarean section 6 years back. Her antenatal and intrapartum course was uneventful. She has no other significant medical or surgical history.
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A decision for laparoscopic management was taken. Routine pre-operative evaluation was carried out and specifically to note whether the shunt was functional, we ruled out any neurological symptoms like headache or visual symptoms. Under general anesthesia, the laparoscopic port was inserted, pelvic evaluation was carried out and a left isthmic ectopic gestation was noted with minimal blood in the POD. The VP shunt catheter was seen in the peritoneum \[Figure [1](#F1){ref-type="fig"}--[3](#F3){ref-type="fig"}\] and 30° Trendelenburg\'s position was given. The average insufflation pressure was maintained below 12 mm Hg with a set flow rate of 12 l/min. Intraoperative vitals were monitored for pulse, BP, oxygenation, ETCO~2~ and electrocardiogram leads. There was no evidence of intraoperative bradycardia, hypertension or desatutarion. The ectopic was treated by a left salpingectomy and the surgery was uneventful. During the procedure, special care was taken to avoid manipulation of the shunt. A 3^rd^ generation cephalosporin was given intraoperatively. The operative time was 25 min from the time of skin incision to closure of the ports. Post-operative, her vitals were monitored and examined for any neurological symptoms and signs such as headache, neck stiffness, and fever. With an uneventful post-operative recovery, she was discharged after 24 h. Patient followed-up after a week without any neurological signs or symptoms
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DISCUSSION {#sec1-3}
==========

There is still controversy regarding the safety of performing laparoscopic surgery in patients with VP shunt and potentially decreased cerebral compliance. In previous studies using minimal monitoring of CSF shunt function limited to clinical observation, laparoscopic procedures were reported as safe and efficient in patients with CSF shunts.\[[@ref3]\] However, animal studies have demonstrated that increased intra-abdominal pressure with gas insufflation and Trendelenburg position could induce a linear increase in ICP reaching 150% over control values with intra-abdominal pressures above 16 mm Hg.\[[@ref4]\] The main advocated mechanisms for increased ICP in the presence of pneumoperitoneum, were increased intra-thoracic pressure,\[[@ref4][@ref5]\] and impaired venous drainage of the lumbar venous plexus,\[[@ref2]\] rather than increased arterial carbon dioxide because of systemic carbon dioxide diffusion.\[[@ref6]\]

Jackman *et al*. observed 19 laparoscopic surgeries in patients with VP shunts with a mean insufflation pressure of 16 mm Hg and an average operative time of 3 h. They did not find clinically significant increased intracranial pressure in patients. Routine anesthetic monitoring should remain the standard of care in the absence of clear evidence to the contrary.\[[@ref7]\]

Fraser *et al*. found no episodes of air embolism one shunt infection in a study conducted over 51 laparoscopy procedures in patients with VP shunts.\[[@ref8]\] Neale *et al*. studied an *in vitro* model with nine shunts subjected to increased back pressure and none of the valves showed any signs of leak associated with the increased back pressure.\[[@ref9]\] The risk of retrograde failure of the valve system has been shown to be minimal even with intra-abdominal pressures as high as 80 mm Hg.\[[@ref10]\]

CONCLUSION {#sec1-4}
==========

The presence of a VP shunt does not appear to have any significant risk in patients undergoing laparoscopic procedures. The risk of retrograde failure of the valve, air embolism, and infection is minimal. The insufflation pressure must be the minimum required and at all-time less than 16 mm Hg. The operative time allowed for such patients would require further evaluation, but around 3 h has proven to be safe. VP shunts should not be a contraindication for laparoscopic surgery. However, it must be carried out with good anesthetic and monitoring facilities
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